Myasthenic Crisis — Management Pathway
Falling FVC/bulbar weakness → ICU respiratory support, hold pyridostigmine, plasma exchange or IVIG, avoid aggravating drugs.
Crisis → ICU + respiratory support: Respiratory/bulbar involvement (crisis): ICU, respiratory support (NIV/BiPAP can avoid some intubations; intubate once clinical indications…
Step-by-step decision
Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.
🎓 Want to practice? Do a case challenge with this pathway → (get a case, choose management step by step, scored).
Full pathway
- [Decision] Respiratory/bulbar involvement?Respiratory/bulbar involvement (single-breath count, FVC)? (MG exacerbation causing respiratory failure needing intubation/NIV, bulbar weakness causing aspiration. Triggers: infection/surgery/pregnancy/drugs (beta-blockers, IV magnesium, fluoroquinolones, aminoglycosides, macrolides). Monitor: single-breath count (unable to reach 20 is a warning), FVC, NIF; generalized weakness can mask respiratory distress. Differentiate from cholinergic crisis (cholinergic excess: SLUDGE, fasciculations).)
- Respiratory/bulbar involvement, falling FVC → Crisis → ICU + respiratory support
- Stable, no respiratory involvement → Stable · monitor + immunotherapy
- [End] Stable · monitor + immunotherapyNo significant respiratory/bulbar involvement: admit for close monitoring — single-breath count, FVC/NIF, bulbar function, cough strength; find and treat the trigger (infection), stop aggravating drugs. May start immunotherapy (PLEX or IVIG) + steroids. Escalate if progressing (FVC <15–20 mL/kg, cannot count to 20, bulbar weakness).
- [End] Crisis → ICU + respiratory supportRespiratory/bulbar involvement (crisis): ICU, respiratory support (NIV/BiPAP can avoid some intubations; intubate once clinical indications are clear, not on numbers alone); hold/reduce pyridostigmine during crisis (reduces secretions and helps distinguish cholinergic crisis); plasma exchange (preferred, faster) or IVIG 0.4 g/kg × 5 days (draw serum antibodies first), plus corticosteroids; find and treat the trigger, avoid aggravating drugs (beta-blockers/magnesium/fluoroquinolones/aminoglycosides/macrolides).
Source guidelines & references
- Myasthenic crisis (EMCrit IBCC; MGFA consensus)
This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.